Abbott, Novartis, and Grifols Resolve DNA Patent Dispute Ahead of Trial

Abbott Laboratories, along with Novartis and Grifols, has reached a settlement in a protracted legal dispute concerning a patent related to a DNA replication method. This development effectively concludes the litigation which was scheduled to proceed to trial in less than a month. For those interested in a more detailed account, additional information can be found in the federal court entry in Illinois.